Fluorescence-guided surgery for osteoradionecrosis of the jaw: a retrospective study
- PMID: 35698727
- PMCID: PMC9201330
- DOI: 10.1177/03000605221104186
Fluorescence-guided surgery for osteoradionecrosis of the jaw: a retrospective study
Abstract
Objective: Osteoradionecrosis of the jaw (ORNJ) is one of the most severe head and neck complications in patients treated with radiotherapy. The goal of treatment is to suppress ORNJ progression. Currently, surgical removal of necrotic bone is an effective management approach for advanced stages. In this study, we present our experience in managing ORNJ using fluorescence-guided surgery.
Methods: Nineteen ORNJ lesions in 15 hospitalized patients were treated with fluorescence-guided surgery. We retrospectively reviewed patients' demographic data, comorbidities, local preceding event, location, ORNJ stage, and treatment outcomes with a median follow-up of 12 months.
Results: Twelve lesions (63%) were treated surgically under tetracycline fluorescence, and seven lesions (37%) were surgically treated under auto-fluorescence. Overall, four lesions (21%) achieved complete mucosal healing, eight lesions (42%) showed partial mucosal healing with bone exposure and no signs or symptoms of inflammation, and seven lesions (37%) were progressive. The results showed that either healing or ORNJ stabilization was achieved in 63% of lesions (n = 12).
Conclusion: Fluorescence-guided surgery can be beneficial in curing or stabilizing ORNJ. However, randomized clinical trials are needed to confirm these findings.
Keywords: Osteoradionecrosis; fluorescence-guided surgery; osteonecrosis of the jaw; osteoradionecrosis of the jaw; patient management; radiotherapy.
Conflict of interest statement
Figures

Similar articles
-
Progression and postoperative complications of osteoradionecrosis of the jaw: a 20-year retrospective study of 124 non-nasopharyngeal cancer cases and meta-analysis.BMC Oral Health. 2022 May 28;22(1):213. doi: 10.1186/s12903-022-02244-9. BMC Oral Health. 2022. PMID: 35643546 Free PMC article.
-
Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma.Radiat Oncol. 2021 Jan 5;16(1):1. doi: 10.1186/s13014-020-01701-5. Radiat Oncol. 2021. PMID: 33402192 Free PMC article.
-
Preoperative status and treatment of osteoradionecrosis of the jaw: a retrospective study of 252 cases.Br J Oral Maxillofac Surg. 2020 Dec;58(10):e276-e282. doi: 10.1016/j.bjoms.2020.07.031. Epub 2020 Aug 5. Br J Oral Maxillofac Surg. 2020. PMID: 32811730
-
Medication-related osteonecrosis and osteoradionecrosis of the jaws: Update and current management.Morphologie. 2021 Jun;105(349):170-187. doi: 10.1016/j.morpho.2020.11.008. Epub 2020 Dec 3. Morphologie. 2021. PMID: 33281055 Review.
-
Pentoxifylline and tocopherol for the treatment of osteoradionecrosis of the jaws. A systematic review.Med Oral Patol Oral Cir Bucal. 2023 May 1;28(3):e293-e300. doi: 10.4317/medoral.25729. Med Oral Patol Oral Cir Bucal. 2023. PMID: 36641743 Free PMC article.
Cited by
-
Resemblances and differences between osteoradionecrosis of the jaw and medication-related osteonecrosis of the jaw.Med Pharm Rep. 2024 Jan;97(1):76-83. doi: 10.15386/mpr-2610. Epub 2024 Jan 29. Med Pharm Rep. 2024. PMID: 38344330 Free PMC article.
-
From Mechanism to Therapy: The Role of MSC-EVs in Alleviating Radiation-Induced Injuries.Pharmaceutics. 2025 May 16;17(5):652. doi: 10.3390/pharmaceutics17050652. Pharmaceutics. 2025. PMID: 40430942 Free PMC article. Review.
References
-
- Nabil S, Samman N. Risk factors for osteoradionecrosis after head and neck radiation: a systematic review. Or Surg or Med or Pa 2012; 113: 54–69. - PubMed
-
- Reuther T, Schuster T, Mende U, et al.. Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients – a report of a thirty year retrospective review. Int J Oral Max Surg 2003; 32: 289–295. - PubMed
-
- Bettoni J, Olivetto M, Duisit J, et al.. The value of reconstructive surgery in the management of refractory jaw osteoradionecrosis: a single-center 10-year experience. Int J Oral Maxillofac Surg 2019; 48: 1398–1404. - PubMed
-
- Rice N, Polyzois I, Ekanayake K, et al.. The management of osteoradionecrosis of the jaws–a review. Surgeon 2015; 13: 101–109. - PubMed
-
- Chrcanovic BR, Reher P, Sousa AA, et al.. Osteoradionecrosis of the jaws–a current overview–Part 2: dental management and therapeutic options for treatment. Oral Maxillofac Surg 2010; 14: 81–95. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources